Congenital Sucrase-isomaltase Deficiency

• CLINICAL_TRIALS trial_result · 2025-03-20
  Clinical Trial Update: 7-Day Trial of Sucraid for Alleviating CSID Symptoms in Subjects With Low, Moderate, and Normal Sucrase Levels [Phase 4]

  Phase 4 clinical trial evaluating Sucraid (sacrosidase) for CSID symptoms across low, moderate, and normal sucrase levels has been terminate…

• FDA label_change · 2024-07-24
  FDA Approved: SUCRAID — Supplemental Application (QOL Medical, LLC)

  FDA approved a supplemental application for SUCRAID (sacrosidase) from QOL Medical, LLC, resulting in changes to the product labeling.

• FDA approval · 2022-05-25
  FDA Approved: SUCRAID — Supplemental Application (QOL Medical, LLC)

  The FDA approved a supplemental application for SUCRAID (sacrosidase) from QOL Medical, LLC.

• CLINICAL_TRIALS research · 2016-10-10
  Clinical Trial Update: Congenital Sucrase-Isomaltase Deficiency (CSID) Genetic Prevalence Study (GPS)

  Completed genetic prevalence study on congenital sucrase-isomaltase deficiency (CSID) with results posted.

• FDA approval · 2014-12-02
  FDA Approved: SUCRAID — Supplemental Application (QOL Medical, LLC)

  The FDA approved a supplemental application for SUCRAID (sacrosidase) filed by QOL Medical, LLC. This action pertains to the regulatory stat…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2013-05-28
  FDA Approved: SUCRAID — Supplemental Application (QOL Medical, LLC)

  FDA approved SUCRAID (sacrosidase) through a supplemental application submitted by QOL Medical, LLC.

• FDA approval · 2011-06-15
  FDA Approved: SUCRAID — Supplemental Application (QOL Medical, LLC)

  The FDA approved a supplemental application for SUCRAID (sacrosidase) submitted by QOL Medical, LLC.

• FDA approval · 2010-12-09
  FDA Approved: SUCRAID — Supplemental Application (QOL Medical, LLC)

  The FDA approved a supplemental application for SUCRAID (sacrosidase) filed by QOL Medical, LLC.

• FDA approval · 2008-11-20
  FDA Approved: SUCRAID — Supplemental Application (QOL Medical, LLC)

  The FDA approved a supplemental application for SUCRAID (sacrosidase) filed by QOL Medical, LLC.

• FDA approval · 2008-02-20
  FDA Approved: SUCRAID — Supplemental Application (QOL Medical, LLC)

  The FDA approved a supplemental application for SUCRAID (sacrosidase) filed by QOL Medical LLC. The approval adds or modifies labeling for t…